Title of securities to be registered
|
Amount to be registered(1)
|
Proposed maximum offering price per share(2)
|
Proposed maximum aggregate offering price(2)
|
Amount of registration fee(2)(3)
|
Common Stock, par value $0.10 per share
|
15,000,000
|
$32.88
|
$493,200,000
|
$35,165.16
|
(1)
|
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of common stock which become issuable under the registrant’s 2007 Equity Incentive Plan by reason of any stock dividend, stock split, recapitalization, merger, consolidation or reorganization of or by the registrant which results in an increase in the number of the registrant’s outstanding shares of common stock.
|
(2)
|
Estimated for the sole purpose of calculating the registration fee. Pursuant to Rule 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share is calculated based upon the average of the high and low selling prices, as reported by the New York Stock Exchange, Inc., of the common stock of the registrant on November 10, 2010.
|
(3)
|
Calculated pursuant to Section 6(b) of the Securities Act, as follows: $71.30 per $1,000,000 of the proposed maximum aggregate offering price.
|
|
EXPLANATORY NOTE
|
4.1
|
Articles of Incorporation of the Company, as amended and restated. Incorporated by reference to the Company’s Quarterly Report on Form 10-Q (Commission File No. 1-5438) for the Quarter ended September 30, 2008.
|
4.2
|
Bylaws of the Company, as amended. Incorporated by reference to the Company’s Current Report on Form 8-K (Commission File No. 1-5438) filed March 2, 2009.
|
4.3
|
2007 Equity Incentive Plan of the Company, as amended. Incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (Commission File No. 1-5438) filed August 11, 2010.
|
4.4
|
Form of Director Restricted Stock Agreement under the 2007 Equity Incentive Plan. Incorporated by reference to the Company’s Registration Statement on Form S-8 (No. 333-145415), filed August 14, 2007.
|
4.5
|
Form of Director Stock Option Agreement under the 2007 Equity Incentive Plan. Incorporated by reference to the Company’s Quarterly Report on Form 10-Q (Commission File No. 1-5438) for the quarter ended September 30, 2007.
|
4.6
|
Form of Employee Restricted Stock Agreement under the 2007 Equity Incentive Plan. Incorporated by reference to the Company’s Annual Report on Form 10-K (Commission File No. 1-5438) for the fiscal year ended March 31, 2008.
|
4.7
|
Form of Employee Stock Option Agreement under the 2007 Equity Incentive Plan of Forest Laboratories, Inc. Incorporated by reference to the Company’s Quarterly Report on Form 10-Q (Commission File No. 1-5438) for the quarter ended September 30, 2007.
|
Opinion of Dornbush Schaeffer Strongin & Venaglia, LLP.
|
23.1
|
Consent of Dornbush Schaeffer Strongin & Venaglia, LLP (included in Exhibit 5.1).
|
Consent of BDO USA, LLP (formerly known as BDO Seidman, LLP).
|
24.1
|
Power of Attorney (included in the signature pages to this registration statement).
|
/s/ Howard Solomon
|
Chairman of the Board,
|
November 16, 2010
|
Howard Solomon
|
Chief Executive
|
|
Officer and Director
|
/s/ Lawrence S. Olanoff, M.D., Ph.D.
|
President, Chief
|
November 16, 2010
|
Lawrence S. Olanoff, M.D., Ph.D.
|
Operating Officer
|
|
and Director
|
|
PRINCIPAL FINANCIAL AND
|
|
ACCOUNTING OFFICER:
|
/s/ Francis I. Perier, Jr.
|
Senior Vice President-
|
November 16, 2010
|
Francis I. Perier, Jr.
|
Finance and Chief
|
|
Financial Officer
|
|
DIRECTORS:
|
/s/ Nesli Basgoz, M.D.
|
Director
|
November 16, 2010
|
|
Nesli Basgoz, M.D.
|
/s/ Kenneth E. Goodman
|
Director
|
November 16, 2010
|
|
Kenneth E. Goodman
|
/s/ George S. Cohan
|
Director
|
November 16, 2010
|
|
George S. Cohan
|
/s/ William J. Candee, III
|
Director
|
November 16, 2010
|
|
William J. Candee, III
|
/s/ Dan L. Goldwasser
|
Director
|
November 16, 2010
|
|
Dan L. Goldwasser
|
/s/ Lester B. Salans, M.D.
|
Director
|
November 16, 2010
|
|
Lester B. Salans, M.D.
|
/s/ Peter J. Zimetbaum, M.D.
|
Director
|
November 16, 2010
|
|
Peter J. Zimetbaum, M.D.
|
4.1
|
Articles of Incorporation of the Company, as amended and restated. Incorporated by reference to the Company’s Quarterly Report on Form 10-Q (Commission File No. 1-5438) for the Quarter ended September 30, 2008.
|
4.2
|
Bylaws of the Company, as amended. Incorporated by reference to the Company’s Current Report on Form 8-K (Commission File No. 1-5438) filed March 2, 2009.
|
4.3
|
2007 Equity Incentive Plan of the Company, as amended. Incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (Commission File No. 1-5438) filed August 11, 2010.
|
4.4
|
Form of Director Restricted Stock Agreement under the 2007 Equity Incentive Plan. Incorporated by reference to the Company’s Registration Statement on Form S-8 (No. 333-145415), filed August 14, 2007.
|
4.5
|
Form of Director Stock Option Agreement under the 2007 Equity Incentive Plan. Incorporated by reference to the Company’s Quarterly Report on Form 10-Q (Commission File No. 1-5438) for the quarter ended September 30, 2007.
|
4.6
|
Form of Employee Restricted Stock Agreement under the 2007 Equity Incentive Plan. Incorporated by reference to the Company’s Annual Report on Form 10-K (Commission File No. 1-5438) for the fiscal year ended March 31, 2008.
|
4.7
|
Form of Employee Stock Option Agreement under the 2007 Equity Incentive Plan of Forest Laboratories, Inc. Incorporated by reference to the Company’s Quarterly Report on Form 10-Q (Commission File No. 1-5438) for the quarter ended September 30, 2007.
|
Opinion of Dornbush Schaeffer Strongin & Venaglia, LLP.
|
23.1
|
Consent of Dornbush Schaeffer Strongin & Venaglia, LLP (included in Exhibit 5.1).
|
Consent of BDO USA, LLP (formerly known as BDO Seidman, LLP).
|
24.1
|
Power of Attorney (included in signature page hereof).
|